Stock Watch: Pharma Businesses That Leave Consumer Behind
Corporate Simplification Risks Discarding Some Valuable And Defensive Attributes
Healthcare conglomerates that divorce consumer, animal health and even generics businesses from their pure-play branded pharmaceutical groups could leave a less diversified and riskier sector in uncertain times. But the advantages are apparent.
